Real Results with EyePromise® DVS
Posted by amess on Nov 21st 2019
With diabetes being such a complicated health concern, it can be intimidating to recommend an eye vitamin. In a case study published by Healio, Drs. Nate Lighthizer and Megan Chee proved that EyePromise DVS fits right into the standard diabetes care protocol and positively impacts patient outcomes.
The Case Study
The study reviewed the case of a 63-year-old Native American woman with an unexplained decrease in vision. Though she took various medications for her diabetes and hypertension, she struggled with poorly controlled diabetes for over 20 years. Testing revealed that the patient had dysfunction in the retina and central macula with no structural abnormalities noted in the OCT or fundus imaging.Diagnosis
Drs. Lighthizer and Chee determined the patient had mild nonproliferative diabetic retinopathy (NPDR) but suspected that the retinopathy was worse than the imaging showed due to the significantly abnormal ERG tests.Solution
After this discovery, Lighthizer and Chee educated the patient on diabetes care and proper blood sugar and pressure control. The doctors also recommended EyePromise DVS to provide support for her eye health. At the 6-month follow-up, she showed improvements in ERG, and she reported noticing improvements in her vision which was supported by improved acuity.Other Clinical Results with EyePromise DVS
While this is just one patient, DVS was studied in a clinical trial with 67 participants. The monumental study reviewed the impact a group of ingredients would have on the health of patients with diabetes. Overall, the results were wildly successful. A few notable results include:- Increased macular pigment by 31%
- Improved color vision by 21%
- Contrast sensitivity improved by 19%
- Improved peripheral vision by 12%
- Doesn’t impact blood sugar levels